{Reference Type}: Journal Article
{Title}: Cancer EV stimulate endothelial glycolysis to fuel protein synthesis via mTOR and AMPKα activation.
{Author}: Beaumont JEJ;Barbeau LMO;Ju J;Savelkouls KG;Bouwman FG;Zonneveld MI;Bronckaers A;Kampen KR;Keulers TGH;Rouschop KMA;
{Journal}: J Extracell Vesicles
{Volume}: 13
{Issue}: 7
{Year}: 2024 Jul
{Factor}: 17.337
{DOI}: 10.1002/jev2.12449
{Abstract}: Hypoxia is a common feature of solid tumours and activates adaptation mechanisms in cancer cells that induce therapy resistance and has profound effects on cellular metabolism. As such, hypoxia is an important contributor to cancer progression and is associated with a poor prognosis. Metabolic alterations in cells within the tumour microenvironment support tumour growth via, amongst others, the suppression of immune reactions and the induction of angiogenesis. Recently, extracellular vesicles (EV) have emerged as important mediators of intercellular communication in support of cancer progression. Previously, we demonstrated the pro-angiogenic properties of hypoxic cancer cell derived EV. In this study, we investigate how (hypoxic) cancer cell derived EV mediate their effects. We demonstrate that cancer derived EV regulate cellular metabolism and protein synthesis in acceptor cells through increased activation of mTOR and AMPKα. Using metabolic tracer experiments, we demonstrate that EV stimulate glucose uptake in endothelial cells to fuel amino acid synthesis and stimulate amino acid uptake to increase protein synthesis. Despite alterations in cargo, we show that the effect of cancer derived EV on recipient cells is primarily determined by the EV producing cancer cell type rather than its oxygenation status.